These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7603201)

  • 41. Anti-hypertensive effects of intravenous compared with oral captopril.
    Sramek JJ; Brennan JJ; Much DR; Duchin K; Luna A; Cutler NR
    J Hum Hypertens; 1995 Nov; 9(11):875-8. PubMed ID: 8583465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Local and general non-immunologic complications of insulin therapy].
    Scapellato L
    Recenti Prog Med; 1973 Dec; 55(6):503-26. PubMed ID: 4592315
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hypoglycemia caused by interference between an angiotensin-converting enzyme inhibitor and a hypoglycemic sulfonamide].
    Veyre B; Ginon I; Vial T; Dragol F; Daumont M
    Presse Med; 1993 Apr; 22(15):738. PubMed ID: 8511130
    [No Abstract]   [Full Text] [Related]  

  • 44. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of angiotensin-converting enzyme inhibition on pituitary hormone responses to insulin-induced hypoglycemia in humans.
    Winer LM; Molteni A; Molitch ME
    J Clin Endocrinol Metab; 1990 Jul; 71(1):256-9. PubMed ID: 2164528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 49. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 50. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What are the disadvantages of sliding-scale insulin?
    Michota F
    J Hosp Med; 2007; 2 Suppl 1():20-2. PubMed ID: 17311240
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
    J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison on intravenous and subcutaneous insulin infusions in man.
    Katsilambros N; Verykokidou H; Philipides P; Moiras G; Daikos GK
    Lancet; 1979 Mar; 1(8116):609-10. PubMed ID: 85192
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin absorption and insulin requirement.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J; Deckert T
    Lancet; 1978 Nov; 2(8097):989. PubMed ID: 82008
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic insulin overtreatment.
    Smith RF; Moore RA; Asplin CM; Hockaday TD
    Lancet; 1979 Sep; 2(8143):634-5. PubMed ID: 90294
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe hypoglycaemia after glibenclamide.
    Gottesbüren H; Gerdes H; Littmann KP; Martini GA
    Lancet; 1970 Sep; 2(7672):576. PubMed ID: 4195248
    [No Abstract]   [Full Text] [Related]  

  • 57. ACE inhibitors and hypoglycaemia.
    Wildenborg IH; Veenstra J; van der Voort PH; Verdegaal WP; Silberbusch J
    Lancet; 1995 Jul; 346(8967):126; author reply 126-7. PubMed ID: 7603201
    [No Abstract]   [Full Text] [Related]  

  • 58. ACE inhibitors and hypoglycaemia.
    Davie AP
    Lancet; 1995 Jul; 346(8967):126; author reply 126-7. PubMed ID: 7603200
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.
    Herings RM; de Boer A; Stricker BH; Leufkens HG; Porsius A
    Lancet; 1995 May; 345(8959):1195-8. PubMed ID: 7739305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE inhibitors and hypoglycaemia.
    Kong N; Bates A; Ryder RE
    Lancet; 1995 Jul; 346(8967):125; author reply 126-7. PubMed ID: 7677857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.